Dishman Carbogen Amcis Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 184.45 as of 12 Jun 15:30 . The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 161 on March 2022 to 1036 on March 2025 . This represents a CAGR of 59.28% over 4 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 49.4 on March 2021 to 38.1 on March 2025 . This represents a CAGR of -5.06% over 5 years The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 1708 crore on March 2021 to ₹ 3411 crore on March 2025 . This represents a CAGR of 14.83% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 143384 crore on March 2021 to ₹ 416392 crore on March 2025 . This represents a CAGR of 23.77% over 5 years The revenue of Dishman Carbogen Amcis Ltd for the Mar '26 is ₹ 867.82 crore as compare to the Dec '25 revenue of ₹ 726.46 crore. This represent the growth of 19.46% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '26 is ₹ 15070 crore as compare to the Dec '25 revenue of ₹ 16099 crore. This represent the decline of -6.39% The ebitda of Dishman Carbogen Amcis Ltd for the Mar '26 is ₹ 178.22 crore as compare to the Dec '25 ebitda of ₹ 119.77 crore. This represent the growth of 48.8% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '26 is ₹ 4412 crore as compare to the Dec '25 ebitda of ₹ 5037 crore. This represent the decline of -12.41% The net profit of Dishman Carbogen Amcis Ltd changed from ₹ -77.57 crore to ₹ 21.74 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2871 crore to ₹ 2723 crore over 8 quarters. This represents a CAGR of -2.60% The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 213.61 % on March 2021 to 89.64 % on March 2025 . This represents a CAGR of -15.94% over 5 years .

About Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Limited was formerly incorporated as 'Carbogen Amcis (India) Limited' on July 17, 2007.
The Company name later on, was changed to 'Dishman Carbogen Amcis Limited' on 27 March 2017.
The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants.
It works manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.
The name of Carbogen Amcis (India) Ltd.

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 2,891 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 433,619 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Sun Pharmaceutical Industries Ltd?

As of June 14, 2026, the Dishman Carbogen Amcis Ltd stock price is INR ₹184.45. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1807.25.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.